Bcl2 and Bcl-XL inhibit the loss of mitochondrial membrane potential mediated by Granzyme B, Bcl-XL, and BNIP3, as well as caspase-mediated apoptosis, thereby promoting cancer cell survival. Here, BCL2L1 is linked to cancer.